News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

EPIRUS Biopharmaceuticals Appoints J. Kevin Buchi to Board of Directors



6/27/2013 7:21:38 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

EPIRUS Biopharmaceuticals, Inc. (EPIRUS), a privately held biotechnology company focused on the development and production of biosimilar products in and for major emerging markets, today announced the appointment of J. Kevin Buchi to its Board of Directors.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES